TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-02-05
DOI
10.1038/s41419-017-0197-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P
- (2016) Bin Huang et al. CANCER LETTERS
- ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L
- (2016) Ronghao Wang et al. CANCER LETTERS
- Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
- (2016) Maja Olsson et al. Epigenetics
- Testosterone Therapy in Men With Prostate Cancer
- (2016) Alan L. Kaplan et al. EUROPEAN UROLOGY
- Reciprocal regulation of long noncoding RNAs THBS4-003 and THBS4 control migration and invasion in prostate cancer cell lines
- (2016) Jinliang Liu et al. Molecular Medicine Reports
- Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients
- (2016) Gong Cheng et al. Oncotarget
- Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence
- (2015) Adrian Ruiz-Hernandez et al. Clinical Epigenetics
- TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins
- (2015) Weihua Zhan et al. PLoS One
- A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer
- (2015) Kee Ming Chia et al. NEOPLASIA
- Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer
- (2014) T. Fujimura et al. CLINICAL CANCER RESEARCH
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer
- (2014) Xuedong Song et al. PROSTATE
- Castration-resistant prostate cancer: Adaptive responses in the androgen axis
- (2013) Alison Egan et al. CANCER TREATMENT REVIEWS
- Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box-Binding Protein-1 Promotes Prostate Cancer Progression
- (2013) K. Imada et al. CLINICAL CANCER RESEARCH
- Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
- (2013) Y. M. Ning et al. CLINICAL CANCER RESEARCH
- Resistance Emerges to Second-Generation Antiandrogens in Prostate Cancer
- (2013) W. G. Nelson et al. Cancer Discovery
- Enzalutamide — A Major Advance in the Treatment of Metastatic Prostate Cancer
- (2012) Nicholas J. Vogelzang NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells
- (2010) K Takayama et al. ONCOGENE
- Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
- (2010) Y Niu et al. ONCOGENE
- Bipolar androgen therapy: The rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer
- (2010) Samuel R. Denmeade et al. PROSTATE
- Decreased TIP30 Expression Promotes Tumor Metastasis in Lung Cancer
- (2009) Xin Tong et al. AMERICAN JOURNAL OF PATHOLOGY
- TRIM36 interacts with the kinetochore protein CENP-H and delays cell cycle progression
- (2009) Naoto Miyajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started